Medicare Coverage Expansion (Mid-2026) In November 2025, the Trump administration announced a landmark deal with Novo Nordisk to expand Medicare coverage for GLP-1 obesity drugs including Wegovy for the first time
Through our care coaching program, we work with you to help you identify the goals you want to reach and the best path to get you there
This exaggerated GLP-1 response stimulates excessive insulin secretion that overshoots, causing blood glucose to drop to hypoglycaemic levels 13 hours after eating
Large primordial planetesimals (big red dots) show high collision velocities (red arrows) leading to destructive collisions (yellow) and producing small, second generation planetesimals (small red dots)
thaliana to infection by the soil-borne necrotrophic fungal pathogen Rhizoctonia solani was investigated using a luciferase reporter system
Its essential to maintain a balanced diet to support overall health and prevent energy imbalances, even while managing appetite suppression with GLP-1 medications
